Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 9 | 2014 | 212 | 1.280 |
Why?
|
| Spheroids, Cellular | 5 | 2014 | 45 | 0.740 |
Why?
|
| Fibroblasts | 9 | 2014 | 902 | 0.520 |
Why?
|
| Heart Valves | 3 | 2012 | 171 | 0.430 |
Why?
|
| Cell Fusion | 1 | 2010 | 23 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2011 | 245 | 0.370 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 199 | 0.360 |
Why?
|
| Blood Vessels | 1 | 2010 | 102 | 0.350 |
Why?
|
| Caveolin 1 | 4 | 2014 | 59 | 0.350 |
Why?
|
| Scleroderma, Systemic | 4 | 2014 | 446 | 0.340 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2014 | 110 | 0.330 |
Why?
|
| Cell Differentiation | 9 | 2014 | 1034 | 0.260 |
Why?
|
| Heart | 3 | 2006 | 850 | 0.260 |
Why?
|
| Printing, Three-Dimensional | 2 | 2014 | 31 | 0.240 |
Why?
|
| Coturnix | 1 | 2003 | 22 | 0.230 |
Why?
|
| Animals | 23 | 2014 | 20877 | 0.230 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 114 | 0.220 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 102 | 0.220 |
Why?
|
| Stem Cells | 4 | 2014 | 248 | 0.210 |
Why?
|
| Rhombencephalon | 1 | 2002 | 7 | 0.210 |
Why?
|
| Embryonic Structures | 1 | 2002 | 3 | 0.210 |
Why?
|
| Elastin | 1 | 2003 | 116 | 0.210 |
Why?
|
| Ear, Inner | 1 | 2002 | 47 | 0.200 |
Why?
|
| Pulmonary Fibrosis | 2 | 2013 | 157 | 0.190 |
Why?
|
| Myocardium | 1 | 2006 | 1204 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2013 | 144 | 0.180 |
Why?
|
| Extracellular Matrix | 2 | 2012 | 493 | 0.180 |
Why?
|
| Mice | 13 | 2014 | 8472 | 0.180 |
Why?
|
| Aorta | 2 | 2013 | 316 | 0.170 |
Why?
|
| Monocytes | 3 | 2014 | 210 | 0.160 |
Why?
|
| Alginates | 2 | 2014 | 35 | 0.150 |
Why?
|
| RNA, Messenger | 6 | 2013 | 1663 | 0.150 |
Why?
|
| Magnetic Phenomena | 2 | 2013 | 12 | 0.150 |
Why?
|
| Magnetite Nanoparticles | 2 | 2013 | 28 | 0.150 |
Why?
|
| Bleomycin | 2 | 2014 | 67 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2011 | 268 | 0.140 |
Why?
|
| Collagen Type I | 5 | 2012 | 175 | 0.140 |
Why?
|
| Cell Movement | 4 | 2014 | 630 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1173 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 2790 | 0.130 |
Why?
|
| Hyaluronan Receptors | 2 | 2013 | 142 | 0.130 |
Why?
|
| Ink | 1 | 2014 | 8 | 0.130 |
Why?
|
| Bioprinting | 1 | 2014 | 11 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2014 | 236 | 0.120 |
Why?
|
| Infusion Pumps | 1 | 2014 | 39 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 33 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 82 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 78 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2014 | 221 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 189 | 0.110 |
Why?
|
| Chick Embryo | 4 | 2012 | 379 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 217 | 0.110 |
Why?
|
| Lung | 2 | 2013 | 849 | 0.100 |
Why?
|
| Mesoderm | 2 | 2012 | 231 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2013 | 2673 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 200 | 0.100 |
Why?
|
| Dermis | 1 | 2010 | 29 | 0.100 |
Why?
|
| Bioreactors | 2 | 2013 | 65 | 0.100 |
Why?
|
| Leukocytes | 1 | 2010 | 99 | 0.090 |
Why?
|
| Morphogenesis | 2 | 2008 | 158 | 0.090 |
Why?
|
| Robotics | 1 | 2010 | 56 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 191 | 0.090 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 282 | 0.080 |
Why?
|
| Genes, Homeobox | 1 | 2008 | 15 | 0.080 |
Why?
|
| Humans | 18 | 2014 | 68525 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 242 | 0.080 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2008 | 24 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 145 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2008 | 85 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2010 | 652 | 0.080 |
Why?
|
| Phenotype | 2 | 2011 | 946 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 710 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 157 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 2 | 2008 | 64 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 84 | 0.080 |
Why?
|
| Glioma | 1 | 2008 | 140 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2013 | 2688 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2008 | 206 | 0.070 |
Why?
|
| Fetal Heart | 1 | 2006 | 41 | 0.070 |
Why?
|
| Regenerative Medicine | 1 | 2006 | 17 | 0.070 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 78 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2008 | 431 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2006 | 108 | 0.070 |
Why?
|
| Anatomy | 1 | 2006 | 36 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2006 | 36 | 0.070 |
Why?
|
| Fibronectins | 2 | 2006 | 130 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 332 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2006 | 100 | 0.070 |
Why?
|
| Organogenesis | 1 | 2005 | 49 | 0.070 |
Why?
|
| Hexuronic Acids | 2 | 2014 | 24 | 0.060 |
Why?
|
| Glucuronic Acid | 2 | 2014 | 25 | 0.060 |
Why?
|
| Receptors, CXCR4 | 2 | 2014 | 48 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 403 | 0.060 |
Why?
|
| Actins | 3 | 2013 | 249 | 0.060 |
Why?
|
| Fibrillins | 1 | 2003 | 24 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 95 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 74 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2003 | 131 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2003 | 282 | 0.060 |
Why?
|
| Rats | 4 | 2013 | 5300 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 1032 | 0.050 |
Why?
|
| Laminin | 1 | 2002 | 62 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 130 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 99 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 115 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2003 | 205 | 0.050 |
Why?
|
| Antibodies | 1 | 2002 | 241 | 0.050 |
Why?
|
| Cell Survival | 2 | 2013 | 901 | 0.050 |
Why?
|
| Endocardium | 2 | 2012 | 101 | 0.050 |
Why?
|
| Male | 7 | 2014 | 37281 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 1447 | 0.050 |
Why?
|
| Female | 7 | 2013 | 38015 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 765 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1640 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2013 | 489 | 0.040 |
Why?
|
| Whole-Body Irradiation | 2 | 2011 | 52 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1293 | 0.040 |
Why?
|
| Clone Cells | 2 | 2006 | 67 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 852 | 0.030 |
Why?
|
| Neoplasms | 1 | 2006 | 1660 | 0.030 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 17 | 0.030 |
Why?
|
| Osmosis | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 84 | 0.030 |
Why?
|
| Apoferritins | 1 | 2013 | 6 | 0.030 |
Why?
|
| Horses | 1 | 2013 | 20 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 62 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Matrix Attachment Regions | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hydrogels | 1 | 2014 | 54 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2013 | 37 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 33 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 155 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2013 | 42 | 0.030 |
Why?
|
| Oxides | 1 | 2013 | 47 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 63 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 263 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 247 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 144 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 322 | 0.030 |
Why?
|
| Cattle | 1 | 2013 | 475 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2013 | 305 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 2012 | 42 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 507 | 0.030 |
Why?
|
| Endocardial Cushions | 1 | 2012 | 20 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2011 | 5 | 0.030 |
Why?
|
| Iron | 1 | 2013 | 197 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 41 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 384 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2012 | 146 | 0.030 |
Why?
|
| Oxygen | 1 | 2013 | 386 | 0.030 |
Why?
|
| Weight Loss | 1 | 2014 | 319 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 123 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2012 | 166 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 230 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5708 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 35 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2011 | 238 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1752 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1548 | 0.020 |
Why?
|
| Quail | 1 | 2008 | 27 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2012 | 384 | 0.020 |
Why?
|
| Lac Operon | 1 | 2008 | 54 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 62 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 181 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 455 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1194 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 160 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 159 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 137 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 483 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 596 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 328 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 562 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 371 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2006 | 21 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1082 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 160 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2006 | 144 | 0.020 |
Why?
|
| Discoidin Domain Receptors | 1 | 2006 | 16 | 0.020 |
Why?
|
| Ligation | 1 | 2006 | 83 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2006 | 29 | 0.020 |
Why?
|
| Microcirculation | 1 | 2006 | 77 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 2006 | 23 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 194 | 0.020 |
Why?
|
| Species Specificity | 1 | 2006 | 302 | 0.020 |
Why?
|
| Vimentin | 1 | 2006 | 47 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1446 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 168 | 0.020 |
Why?
|
| Polymers | 1 | 2008 | 244 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2006 | 85 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 14842 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 233 | 0.020 |
Why?
|
| Perfusion | 1 | 2006 | 131 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 100 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2006 | 179 | 0.020 |
Why?
|
| Hypoxia | 1 | 2006 | 169 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2006 | 113 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 705 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 1027 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2005 | 208 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 500 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5719 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 21119 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 21375 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2003 | 75 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 122 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2003 | 104 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 2083 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 144 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 442 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2550 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 756 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 1849 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8903 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 2331 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1070 | 0.010 |
Why?
|
| United States | 1 | 2006 | 7335 | 0.010 |
Why?
|